The EPO acknowledges patentability on Pharmistas international PCT application

Written By Alice Mattsson

Pharmista receives an International Preliminary Report on Patentability (IPRP) from the EPO.

Alice Mattsson
Previous

Introducing Annette Säfholm as the chairman of the board
Next

Pharmista receives funding from the EU